A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

NCT05947097 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: HSK21542 Injection

Sponsor

Haisco Pharmaceutical Group Co., Ltd.